Les nouveaux anticoagulants oraux : halte à la polémique !

dc.contributor.authorSmadja, David M.
dc.date.accessioned2020-01-23T09:11:58Z
dc.date.available2020-01-23T09:11:58Z
dc.date.issued2013-10
dc.descriptionp.1044-1047en_US
dc.identifier.issn0035-2640
dc.identifier.urihttp://repository.usthb.dz//xmlui/handle/123456789/7988
dc.language.isofren_US
dc.relation.ispartofseriesIn : Revue du Praticien, T63, n°8 (Oct. 2013);
dc.subjectAnticoagulants oraux directsen_US
dc.subjectNACO (pharmacie)en_US
dc.subjectAntivitamines Ken_US
dc.subjectAVKen_US
dc.subjectPradaxa (dabigatran)en_US
dc.subjectXarelto (rivaroxaban)en_US
dc.subjectEliquis (apixaban)en_US
dc.titleLes nouveaux anticoagulants oraux : halte à la polémique !en_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
res.pdf
Size:
26.46 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: